Clarametyx Biosciences at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Clarametyx Biosciences brings 1 presentation to IDWeek 2026 in Washington, and exhibits at Booth 1624. Its program centres on its approach to chronic respiratory disease. It describes science meant to help the immune system act on what drives these conditions upstream.

OrganizationIDWeek 2026 Attendance
clarametyx.com
Biotech
Biotech developing antibody therapies and vaccines that break down bacterial biofilms, aiding immune and antibiotic clearance of chronic respiratory infections.
Booth
Exhibiting at Booth 1624
Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm
Industry
Fri Oct 23
8:12am–8:24am
Part of New Antimicrobials in the Pipeline
Clarametyx Biosciences: Novel immune-enabling science addresses upstream drivers of chronic respiratory disease
206
Antimicrobials, resistance and stewardshipRespiratory infections and COVID-19

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Clarametyx Biosciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction